# Biorez

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biorez

- Industry: Medical Devices & Equipment
- Headquarters: New Haven, US
- Website: www.biorez.com
- Total disclosed funding: $11M
- Latest round: Series C (Mar 5, 2018)
- Investors on record: 7

## About

Biorez, Inc. is a medical technology company focused on developing innovative biological implants aimed at enhancing soft tissue healing and regeneration in various orthopedic procedures.Founded in 2008 and headquartered in New Haven, US, Biorez, Inc. specializes in biocomposite implants that promote tissue regeneration. The company was acquired by CONMED Corporation in August 2022 for USD 250 mn, enhancing its growth strategy and technological capabilities. The CEO, Kevin Rocco, leads the company following the acquisition, which involved notable investors such as Virginia Venture Partners and MentorTech Ventures.Biorez, Inc. produces advanced medical devices, particularly the BioBrace® Reinforced BioInductive Implant. This product is designed to improve soft tissue augmentation through its unique 3D collagen sponge structure, which supports healing in orthopedic surgeries like ACL reconstruction and rotator cuff repairs. Their products are available in various international markets including the US, Canada, Europe, and parts of Latin America and Asia, primarily targeting hospitals and orthopedic specialists.Biorez, Inc.'s revenue model is primarily driven by direct sales of its innovative medical devices, including the BioBrace® Implant. Sales occur through B2B transactions with healthcare providers, ensuring the availability of their products in surgical settings. Although detailed pricing information remains undisclosed, their revenue generation reflects a focus on quality and effectiveness in the medical community.Following its acquisition by CONMED Corporation in August 2022, Biorez, Inc. aims to accelerate the global growth of its technology. The investment will facilitate the expansion into new markets and the development of upcoming products. The recent funding will be utilized to enhance their product offerings and expand their reach into international markets, contributing to the company’s strategy for sustainable growth.

## Funding rounds

- Series C, Mar 5, 2018, $1.5M — Connecticut Innovations, Vertical Group, LaunchCapital, New York Angels
- Series C, Mar 14, 2017, $1.5M — Connecticut Innovations, Vertical Group, Brainchild Holdings, KLP Ventures
- Series B, Nov 7, 2014, $2.9M — MentorTech Ventures, Connecticut Innovations, Vertical Group, LaunchCapital
- Series A, Apr 23, 2010, $0.5M — Connecticut Innovations
- Series A, Jun 30, 2009, $1.1M — MentorTech Ventures, Connecticut Innovations
- Series A, Sep 15, 2008, $3.5M — MentorTech Ventures

## Investors

- MentorTech Ventures (https://capitalatlas.ai/funds/mentortech-ventures) — Series A, Series B
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A, Series B, Series C
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series B, Series C
- LaunchCapital (https://capitalatlas.ai/funds/launchcapital) — Series B, Series C
- Brainchild Holdings (https://capitalatlas.ai/funds/brainchild-holdings) — Series C
- KLP Ventures — Series C
- New York Angels (https://capitalatlas.ai/funds/new-york-angels) — Series C